Takeda Pharmaceutical Co Ltd
XBER:TKD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
Takeda Pharmaceutical Co Ltd
XBER:TKD
|
JP |
|
HealthBank Holdings Ltd
SGX:40B
|
SG |
|
JD Sports Fashion PLC
LSE:JD
|
UK |
|
A
|
Avid Technology Inc
F:AVD
|
US |
|
F
|
Field Trip Health & Wellness Ltd
XTSX:FTHW
|
CA |
|
Studio City International Holdings Ltd
NYSE:MSC
|
HK |
|
B
|
Bank of America Corp
SGO:BAC
|
US |
|
Editas Medicine Inc
NASDAQ:EDIT
|
US |
|
Societal CDMO Inc
F:RAH
|
US |
|
Medexus Pharmaceuticals Inc
TSX:MDP
|
CA |
|
F
|
Fonix Mobile PLC
F:FOS
|
UK |
|
C
|
Cartesian Growth Corporation II
NASDAQ:RENE
|
US |
|
F
|
Fujitsu General Ltd
SWB:29F
|
JP |
|
O
|
Opus Global Nyrt
BET:OPUS
|
HU |
|
A
|
Alamos Gold Inc
NYSE:AGI
|
CA |
Wall Street
Price Targets
TKD Price Targets Summary
Takeda Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for
TKD
is 26.33 EUR
with a low forecast of 21 EUR and a high forecast of 31.12 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is TKD's stock price target?
Price Target
26.33
EUR
According to Wall Street analysts, the average 1-year price target for
TKD
is 26.33 EUR
with a low forecast of 21 EUR and a high forecast of 31.12 EUR.
What is Takeda Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
1%
For the last 13 years the
compound annual growth rate for
Takeda Pharmaceutical Co Ltd's revenue is
9%.
The projected
CAGR
for the next 3 years is
1%.
What is Takeda Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
-5%
For the last 13 years the
compound annual growth rate for
Takeda Pharmaceutical Co Ltd's operating income is
6%.
The projected
CAGR
for the next 2 years is
-5%.
What is Takeda Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
46%
For the last 13 years the
compound annual growth rate for
Takeda Pharmaceutical Co Ltd's net income is
-1%.
The projected
CAGR
for the next 3 years is
46%.
